Follow Us 
Clinical Cancer Details
| Protocol No.: | NSABP B-40 | ||
| Title: | A Randomized Phase III Trial of Neoadjuvant Therapy in Patients with Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel when Administered Before AC with or without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR with Each of the Regimens. | ||
| Staging: | Stage 1, Stage 2, | ||
| Objective: | The National Surgical Adjuvant Breast and Bowel Project (NSABP) has a long history of conducting clinical trials evaluating pre-operative or primary chemotherapy in the treatment of patients with operable breast cancer. The proposed trial represents the next logical step in the evolution of this treatment approach and builds on the results of clinical trials and correlative science studies performed by the NSABP as well as by other investigators. | ||
| Overview: |
| ||
| Eligibility Requirements: |
| ||
| Contact: | Center for Oncology 303 N. Clyde Morris Blvd. Daytona Beach, Florida 32114 386.254.4213 Debbie Reynolds, RN, OCN Center for Oncology 303 N. Clyde Morris Blvd. Daytona Beach, Florida 32114 386.254.4213 Kathleen Brady, RN, BA |
